<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:49:35Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3738108" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:3738108</identifier><datestamp>2013-08-14</datestamp><setSpec>bsr</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Biosci Rep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Biosci. Rep</journal-id>
      <journal-id journal-id-type="pmc">bsr</journal-id>
      <journal-id journal-id-type="publisher-id">BSR</journal-id>
      <journal-title-group>
        <journal-title>Bioscience Reports</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0144-8463</issn>
      <issn pub-type="epub">1573-4935</issn>
      <publisher>
        <publisher-name>Portland Press Ltd.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC3738108</article-id>
      <article-id pub-id-type="pmcid">PMC3738108</article-id>
      <article-id pub-id-type="pmc-uid">3738108</article-id>
      <article-id pub-id-type="pmid">23815679</article-id>
      <article-id pub-id-type="publisher-id">e00056</article-id>
      <article-id pub-id-type="doi">10.1042/BSR20130045</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Paper</subject>
        </subj-group>
        <subj-group subj-group-type="Primary">
          <subject>S2</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Conformational stability and activity analysis of two hydroxymethylbilane synthase mutants, K132N and V215E, with different phenotypic association with acute intermittent porphyria</article-title>
        <alt-title alt-title-type="right-running-head">Acute intermittent porphyria-associated mutations</alt-title>
        <alt-title alt-title-type="left-running-head">H.J. Bustad and others</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bustad</surname>
            <given-names>HeleneÂ J.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">*</xref>
          <xref ref-type="aff" rid="A2">â </xref>
          <xref ref-type="corresp" rid="COR1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vorland</surname>
            <given-names>Marta</given-names>
          </name>
          <xref ref-type="aff" rid="A3">â¡</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>RÃ¸nneseth</surname>
            <given-names>Eva</given-names>
          </name>
          <xref ref-type="aff" rid="A3">â¡</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sandberg</surname>
            <given-names>Sverre</given-names>
          </name>
          <xref ref-type="aff" rid="A2">â </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Martinez</surname>
            <given-names>Aurora</given-names>
          </name>
          <xref ref-type="aff" rid="A1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Toska</surname>
            <given-names>Karen</given-names>
          </name>
          <xref ref-type="aff" rid="A3">â¡</xref>
        </contrib>
        <aff id="A1">*Department of Biomedicine, University of Bergen, 5009 Bergen, Norway</aff>
        <aff id="A2">â Department of Global Public Health and Primary Care, University of Bergen, 5009 Bergen, Norway</aff>
        <aff id="A3">â¡Norwegian Porphyria Centre (NAPOS), Laboratory of Clinical Biochemistry, Haukeland University Hospital, 5021 Bergen, Norway</aff>
      </contrib-group>
      <author-notes>
        <corresp id="COR1"><sup>1</sup>To whom correspondence should be addressed (email <email>helenejbustad@gmail.com</email>).</corresp>
      </author-notes>
      <pub-date pub-type="epreprint">
        <day>2</day>
        <month>7</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>8</day>
        <month>8</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <volume>33</volume>
      <issue>4</issue>
      <elocation-id>e00056</elocation-id>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>4</month>
          <year>2013</year>
        </date>
        <date date-type="rev-recd">
          <day>23</day>
          <month>5</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>5</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© yyyy The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY)(http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>The autosomal dominantly inherited disease AIP (acute intermittent porphyria) is caused by mutations in HMBS [hydroxymethylbilane synthase; also known as PBG (porphobilinogen) deaminase], the third enzyme in the haem biosynthesis pathway. Enzyme-intermediates with increasing number of PBG molecules are formed during the catalysis of HMBS. In this work, we studied the two uncharacterized mutants K132N and V215E comparative with wt (wild-type) HMBS and to the previously reported AIP-associated mutants R116W, R167W and R173W. These mainly present defects in conformational stability (R116W), enzyme kinetics (R167W) or both (R173W). A combination of native PAGE, CD, DSF (differential scanning fluorimetry) and ion-exchange chromatography was used to study conformational stability and activity of the recombinant enzymes. We also investigated the distribution of intermediates corresponding to specific elongation stages. It is well known that the thermostability of HMBS increases when the DPM (dipyrromethane) cofactor binds to the apoenzyme and the holoenzyme is formed. Interestingly, a decrease in thermal stability was measured concomitant to elongation of the pyrrole chain, indicating a loosening of the structure prior to product release. No conformational or kinetic defect was observed for the K132N mutant, whereas V215E presented lower conformational stability and probably a perturbed elongation process. This is in accordance with the high association of V215E with AIP. Our results contribute to interpret the molecular mechanisms for dysfunction of HMBS mutants and to establish genotypeâphenotype relations for AIP.</p>
      </abstract>
      <kwd-group kwd-group-type="kwd">
        <kwd>acute intermittent porphyria (AIP)</kwd>
        <kwd>genotypeâphenotype relationships</kwd>
        <kwd>hydroxymethylbilane synthase</kwd>
        <kwd>ligandâprotein interaction</kwd>
        <kwd>porphobilinogen (PBG) deaminase</kwd>
        <kwd>thermal stability</kwd>
      </kwd-group>
      <kwd-group kwd-group-type="abbr">
        <kwd>AIP, acute intermittent porphyria</kwd>
        <kwd>ALA, Î´-aminolaevulinic acid</kwd>
        <kwd>DPM, dipyrromethane</kwd>
        <kwd>DSF, differential scanning fluorimetry</kwd>
        <kwd>DTT, dithiothreitol</kwd>
        <kwd>eHMBS, erythroid hydroxymethylbilane synthase</kwd>
        <kwd>HMB, hydroxymethylbilane</kwd>
        <kwd>HMBS, hydroxymethylbilane synthase</kwd>
        <kwd>HUS, Haukeland University Hospital</kwd>
        <kwd>NAPOS, Norwegian Porphyria Centre</kwd>
        <kwd>NPR, Norwegian Porphyria Registry</kwd>
        <kwd>PBG, porphobilinogen</kwd>
        <kwd><italic>T</italic><sub>m</sub>, half-denaturation temperature</kwd>
        <kwd>u-ALA, urinary Î´-aminolaevulinic acid</kwd>
        <kwd>u-PBG, urinary porphobilinogen</kwd>
        <kwd>wt, wild-type</kwd>
      </kwd-group>
      <counts>
        <fig-count count="5"/>
        <table-count count="4"/>
        <ref-count count="50"/>
        <page-count count="10"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>The porphyrias are a group of rare metabolic disorders caused by malfunction of the enzymes in the haem biosynthesis pathway. Mutations in the third enzyme of this synthesis, HMBS [hydroxymethylbilane synthase; also known as PBG (porphobilinogen) deaminase, EC 2.5.1.61] are associated with the most frequently occurring acute porphyria, AIP (acute intermittent porphyria), an autosomal dominant inherited disease. Increased demand for haem, and thus an up-regulation of the haem biosynthesis, is induced by hormonal, environmental and metabolic factors among others. With deficient HMBS activity, an up-regulated haem biosynthesis results in accumulation of the haem precursors ALA (Î´-aminolaevulinic acid) and PBG in tissues, which may trigger acute attacks (for reviews, see [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]). To date, more than 385 different mutations in the <italic>HMBS</italic> gene have been reported (available at <ext-link ext-link-type="uri" xlink:href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=HMBS">http://www.hgmd.cf.ac.uk/ac/gene.php?gene=HMBS</ext-link>). Loss of important salt bridges or other intramolecular interactions because of mutations can lead to different effects on enzyme kinetics, stability, flexibility and dynamics of the enzyme. In this work, two uncharacterized Norwegian mutants, K132N and V215E, are compared with wt (wild-type) HMBS and the previously reported AIP-associated mutants R116W, R167W and R173W, which present defects mainly in conformational stability (R116W), enzyme kinetics (R167W) or both (R173W). See Supplementary Figure S1 (at <ext-link ext-link-type="uri" xlink:href="http://www.bioscirep.org/bsr/033/bsr033e056add.htm">http://www.bioscirep.org/bsr/033/bsr033e056add.htm</ext-link>) for a structural model and localization of the mutants.</p>
      <p>Two HMBS isoforms have been reported in humans [<xref ref-type="bibr" rid="B3">3</xref>]; a housekeeping enzyme, referred to as HMBS (361 amino acids; M<sub>w</sub> 39 330), which is ubiquitously expressed and active in all tissues, and an erythroid form [eHMBS (erythroid hydroxymethylbilane synthase), 344 amino acids; M<sub>w</sub> 37 699] lacking 17 residues in the N-terminal. There seems to be no differences in <italic>V</italic><sub>max</sub> or <italic>K</italic><sub>m</sub> between the two isoforms [<xref ref-type="bibr" rid="B4">4</xref>]. The available crystal structure of human HMBS is valuable as a starting point to interpret the pathogenic mechanism for AIP-associated HMBS mutations [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>] (PDB ID 3ECR), but it has not provided information on the 17 N-terminal residues that differ between the isoforms. The monomeric enzyme is organized in three domains (Supplementary Figure S1). Domain 1 (residues 1â116 and 216â239) and domain 2 (residues 117â215) are connected by a hinge region that introduce flexibility, whereas the hydrophobic cleft that is formed between the two domains defines the active site. Domain 3 (C-terminus, residues 240â361) holds a loop containing a conserved cysteine (Cys<sup>261</sup>) to which the DPM (dipyrromethane) cofactor binds covalently.</p>
      <p>HMBS is thought to be expressed as an apoenzyme with a unique ability to assemble its own cofactor. The enzyme catalyses the assembly of four PBG molecules into the linear precursor of uroporphyrinogen III, HMB (hydroxymethylbilane, also called preuroporphyrinogen). Four enzymeâintermediate complexes emerge during this process (for a review, see [<xref ref-type="bibr" rid="B7">7</xref>]). The first three complexes (ES, ES<sub>2</sub> and ES<sub>3</sub>) are relatively stable, whereas the fourth complex, ES<sub>4</sub>, is quickly hydrolysed into HMB [<xref ref-type="bibr" rid="B8">8</xref>]. The cofactor itself is not turned over and HMBS leaves the reaction as a holoenzyme [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>]. The catalytic process of HMBS has been extensively studied [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B10">10</xref>â<xref ref-type="bibr" rid="B12">12</xref>], but the mechanism is still not fully understood. Several salt bridges and hydrogen bonds are established when the cofactor binds to HMBS, inducing additional interactions within the enzyme and cross-linking the domains [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B13">13</xref>]. These interactions lead to a stable structure that is resistant to both heat treatment and urea denaturation [<xref ref-type="bibr" rid="B14">14</xref>â<xref ref-type="bibr" rid="B16">16</xref>]. However, the subsequent condensation of the four PBG molecules is thought to induce conformational changes leading to an opening of the enzyme, giving space for the tetrapyrrole [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>].</p>
      <p>In this work, we aimed to further characterize malfunctioning mechanisms of HMBS mutants, and selected four natural mutations found in Norwegian AIP patients (R116W, R167W, R173W and V215E). In addition, K132N, detected in a patient presented with abdominal pain and indistinct porphyria-related biochemical findings, was included. We studied the conformational and thermal stability of recombinant wt HMBS and the five selected mutants. K132N, carrying a mutation located on the surface, far from the active site, has to our knowledge not previously been reported. V215E, although reported [<xref ref-type="bibr" rid="B17">17</xref>], has not been characterized. V215E is located in the hinge region between domains 1 and 2, close to the active site and is one of the most common AIP mutations in Norway. 59% of patients with this mutation experience porphyria attacks. The results of the novel mutants were validated by comparative analyses with the already characterized mutants R116W [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B18">18</xref>], R167W [<xref ref-type="bibr" rid="B19">19</xref>â<xref ref-type="bibr" rid="B21">21</xref>] and R173W [<xref ref-type="bibr" rid="B21">21</xref>â<xref ref-type="bibr" rid="B24">24</xref>]. These three mutations were chosen because of their different effects on the activity and conformational stability of HMBS. The kinetic failure of R116W can be associated with a strong conformational defect causing a severely misfolded enzyme unable to acquire the cofactor [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. The misfolded R173W mutation has also been shown to be catalytically deleterious, and it is assumed that the substitution of the arginine residue will lead to an improper binding of cofactor and substrate, resulting in blocking of catalysis [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B26">26</xref>]. Furthermore, R167W is a catalytic mutant expected to have an inefficient elongation process, that consequently accumulates enzymeâintermediate complexes [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>].</p>
      <p>By using a combination of methods including native PAGE, enzyme kinetics, CD, DSF (differential scanning fluorimetry) and ion-exchange chromatography, we provide the comparative results on the wt HMBS and selected mutants that contribute to a better understanding of the elongation mechanism and the molecular basis of the dysfunctions of AIP associated mutations. R116W and R173W, which are the two mutants with the most severe phenotype, also present an almost total kinetic dysfunction that is largely related to their severe conformational instability. For the mutants R167W and V215E, which present a less severe phenotype, but yet a high association with AIP, the clinical profile appears to be related to a kinetic and a conformational instability, respectively. For K132N, no defect in enzyme kinetics, conformation or stability could be shown, which seems to fit with the lack of a clear phenotypic association with AIP for this mutant.</p>
    </sec>
    <sec>
      <title>EXPERIMENTAL</title>
      <sec>
        <title>Patients</title>
        <p>Of all known porphyria patients in Norway, 70% are registered in the NPR (Norwegian Porphyria Registry) administered by the NAPOS (Norwegian Porphyria Centre). The register holds patients who have experienced symptoms or attacks because of their porphyria (designated <italic>active</italic>) as well as patients with <italic>latent</italic> porphyria who have never had symptoms that could be attributed to porphyria (mostly relatives of patients predictively examined by DNA sequence analysis). Each patient answers a disease-specific questionnaire, and information on diagnosis, symptoms, biochemical and genetic characteristics, is recorded. A total of 680 patients with AIP, all heterozygote, are registered in the NPR. Of these, 18 (15 active) have the R116W mutation, four patients (three active) are registered with R167W and another four (three active) with the R173W mutation. V215E is registered with 37 (22 active) patients in the NPR. The mutation K132N was discovered in a patient where sequencing of the <italic>HMBS</italic> gene was performed on the basis of abdominal pain and unclear porphyria-related biochemical findings. Following further biochemical studies, neither the index K132N patient nor the nine family members confirmed to have the LysâAsn substitution have at any time presented biochemical findings consistent with a diagnosis of AIP.</p>
        <p>Biochemical diagnosis of AIP was performed at the Laboratory of Clinical Biochemistry, HUS (Haukeland University Hospital). AIP has been established on the basis of increased u-ALA (urinary ALA) and u-PBG (urinary PBG) measured by ion-exchange chromatography [<xref ref-type="bibr" rid="B29">29</xref>] in relation to creatinine, and by reduced eHMBS activity measured in washed erythrocytes as described by Ford et al. [<xref ref-type="bibr" rid="B29">30</xref>]. DNA analyses were carried out at the Centre for Medical Genetics and Molecular Medicine, HUS.</p>
        <p>The study was approved by the Regional Committee for Medical Research Ethics, and informed consent was gathered from all patients.</p>
      </sec>
      <sec>
        <title>Site-directed mutagenesis</title>
        <p>The plasmid for protein expression of human HMBS was generously provided by Professor Pavel Martasek and Dana Ulbrichova as pGEX4T-1-expression vector [<xref ref-type="bibr" rid="B31">31</xref>]. The missense mutations R116W, K132N, R167W, R173W and V215E were introduced into HMBS cDNA using QuikChangeÂ® lightning mutagenesis kit (Stratagene). To verify the mutations, the entire gene was sequenced.</p>
      </sec>
      <sec>
        <title>Expression and purification of HMBS proteins</title>
        <p>Wt and mutant HMBS were expressed in <italic>Escherichia coli</italic> BL21 (DE3) pLysS (Stratagene) as glutathione S-transferase fusion proteins. After inoculation with 50Â ml overnight pre-cultures the cells were grown at 37Â°C in 950Â ml Luria Bertani broth supplemented with 100Â Î¼M ampicillin, 34Â Î¼g/ml chloramphenicol and 2Â g/l glucose. At <italic>A</italic><sub>600</sub>~0.8 protein expression was induced by 1Â mM IPTG (isopropyl thio-Î²-<sc>d</sc>-galactoside), grown overnight at 28Â°C, and harvested by centrifugation at 4Â°C, 4000Â <bold><italic>g</italic></bold> for 15Â min. Washed cells were subsequently resuspended in PBS (140Â mM NaCl, 2.7Â mM KCl, 10Â mM Na<sub>2</sub>HPO<sub>4</sub> and 1.8Â mM KH<sub>2</sub>PO<sub>4</sub>), pH 7.4, containing 1Â mM EDTA, 0.5Â mM PMSF, 1Â mM benzamidine and protease inhibitor (cOmplete ULTRA tablet, Roche Applied Science), and sonicated on ice. The sonicate was centrifuged at 14 000Â <bold><italic>g</italic></bold> for 45Â min at 4Â°C, before the supernatant was loaded onto a glutathione-sepharose 4B column (GE Healthcare), and washed with 500Â ml PBS containing 1Â mM EDTA, followed by two column volumes of only PBS. The thrombin (200Â units/l) digest was performed by gently shaking at 4Â°C for 2Â h in 50Â mM TrisâHCl, pHÂ 8.0, containing 2Â mM CaCl<sub>2</sub>, 1Â mM DTT (dithiothreitol) and 150Â mM NaCl. The final purified proteins, in 50Â mM TrisâHCl, pHÂ 8.0, were up-concentrated (&gt;10Â mg/ml) with 30Â kDa cut-off filters (Amicon Ultra centrifugal filters, Millipore), aliquoted and stored in liquid N<sub>2</sub> until use. The purity of the protein was confirmed by SDSâPAGE.</p>
      </sec>
      <sec>
        <title>Enzymatic activity assay of recombinant HMBS</title>
        <p>The enzymatic activity of recombinant HMBS was assayed in 50Â mM Na-Hepes, pHÂ 8.2, containing 0.1Â M DTT. Approx. 5Â Î¼g enzyme was pre-incubated for 3Â min at 37Â°C and the enzyme reaction was initiated by the addition of 100Â Î¼M preheated PBG solution. After 4Â min the reaction was terminated by the addition of 5Â M HCl and benzoquinone (0.1% in methanol) and samples were incubated on ice for 30Â min, protected from light, before the absorbance was determined at 405Â nm. The activity of recombinant HMBS was defined as nmol of uroporphyrinogen I/h per mg of enzyme at 37Â°C under the given assay conditions. <italic>K</italic><sub>m</sub> and <italic>V</italic><sub>max</sub> were determined using varying PBG concentrations ranging from 1.5Â Î¼M to 4Â mM. Protein concentrations were determined from the theoretical molar extinction coefficients (Ïµ<sub>280</sub>=0.39 for wt, V215E and K132N, and Ïµ<sub>280</sub>=0.54 for R116W, R167W and R173W, for a 0.1% solution) [<xref ref-type="bibr" rid="B32">32</xref>]. The kinetic parameters were obtained by non-linear curve fitting using Sigma Plot 11.0 with the additional module EKWizard 1.2.0.0.</p>
      </sec>
      <sec>
        <title>Anion-exchange chromatography</title>
        <p>The enzyme (~1Â mg of wt or ~3Â mg of V215E) was applied to a MiniQ 4.6/50 PE column (GE Healthcare) equilibrated in 50Â mM TrisâHCl, pHÂ 8.2 at 4Â°C, attached to a Bio-Rad Biologic Duo Flow FPLC system. Elution was performed using a pre-programmed NaCl gradient (0â400Â mM NaCl) with collection of 200Â Î¼l fractions, and the absorbance was monitored at 280Â nm. The individual peaks were collected and up-concentrated using Amicon Ultra 30Â kDa cut-off centrifugal filters (Millipore) for further analysis by DSF.</p>
      </sec>
      <sec>
        <title>Polyacrylamide gel electrophoresis</title>
        <p>10% (w/v) SDS- and native PAGE were both performed in a discontinuous system (stacking gel buffer pHÂ 6.8 and running gel buffer pHÂ 8.8) with Trisâglycine tank buffer (pHÂ 8.3) at room temperature (22Â°C) [<xref ref-type="bibr" rid="B33">33</xref>]. Native PAGE was performed without denaturing agents (SDS, 2-mercaptoethanol) and samples were not heated prior to loading [<xref ref-type="bibr" rid="B16">16</xref>]. Approx. 5 and 10Â Î¼g enzyme were applied for SDSâPAGE and native PAGE, respectively.</p>
      </sec>
      <sec>
        <title>Circular dichroism</title>
        <p>A Jasco J-810 spectropolarimeter equipped with a PTC-348WI Peltier element for temperature control at 25Â°C and a 300Â Î¼l quartz cell with a path length of 1Â mm were used for far-UV and thermal denaturation CD measurements. The HMBS samples (final concentrations 5â9Â Î¼M) were prepared in 10Â mM K-phosphate, pHÂ 8.2, 150Â mM KF. Four scans were accumulated for each spectrum and buffer scans were subtracted, using the accompanying software from Jasco. Thermal denaturation profiles were obtained by recording the ellipticity at 222Â nm as a function of temperature between 20 and 95Â°C (2Â°C/min). The far-UV and thermal scans were smoothed using a negative exponential algorithm with a sample proportion=0.05 and polynomial degree=2 (1 for thermal scans). CDNN [<xref ref-type="bibr" rid="B34">34</xref>] was used to estimate the secondary structure content. The thermal scans were normalized and curve fitted to a two-state unfolding model [<xref ref-type="bibr" rid="B35">35</xref>] and converted to fraction of unfolded protein [<xref ref-type="bibr" rid="B36">36</xref>]. The slope was fixed to zero (md=0) for post-transitional baseline.</p>
      </sec>
      <sec>
        <title>Differential scanning fluorimetry</title>
        <p>A LightCycler 480 Real-Time PCR System (Roche Applied Science) was used for the fluorimetric thermal denaturation scans. 50Â Î¼l of either 2.5Â Î¼M HMBS or mutants in 10Â mM K-phosphate, pHÂ 8.2, 150Â mM KF and 5Ã SYPRO Orange (Molecular Probes, Inc.) were added to each well of a 96-well plate (Roche Applied Science). The plates were incubated for 30Â min at room temperature prior to thermal scans. The increase in SYPRO Orange fluorescence is associated with protein unfolding (Î»<sub>ex</sub>=465Â nm, Î»<sub>em</sub>=610Â nm) and was used for monitoring the thermal denaturation. The thermal scans were performed at a scan rate of 2Â°C/min from 20 to 95Â°C with data points collected approximately every 0.2Â°C. The data were scaled to reflect the fraction of unfolded protein. <italic>T</italic><sub>m</sub> (half-denaturing temperature)-values were determined at fraction of unfolded=0.5, as well as from the maxima of the first derivative.</p>
        <p>Titration experiments by DSF were performed under identical conditions as above, except that 1, 25, 50 or 100Â Î¼M PBG was added to wt or mutants. R167W was additionally titrated with 500 and 1000Â Î¼M PBG.</p>
      </sec>
    </sec>
    <sec>
      <title>RESULTS AND DISCUSSION</title>
      <sec>
        <title>Patient data</title>
        <p>The mean values of eHMBS activity, u-ALA and u-PBG were within the reference limits for the patients with the K132N mutation. The mean levels of eHMBS activity for the other four mutations were all below the lower reference limit. The results are summarized in <xref ref-type="table" rid="T1">Table 1</xref>. The analyses indicate a very severe phenotype for the patients with the R116W and R173W mutations, and severe for R167W and V215E. The biochemical analyses did not reveal any effect of the K132N mutation on the biochemical phenotype.</p>
        <table-wrap id="T1" position="float">
          <label>Table 1</label>
          <caption>
            <title>eHMBS activity, and u-ALA and u-PBG concentrations in AIP patients with the selected HMBS mutations, compared with healthy individuals</title>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th rowspan="1" colspan="1"/>
                <th rowspan="1" colspan="1"/>
                <th colspan="2" rowspan="1">eHMBS (units/l)<xref ref-type="table-fn" rid="T1TFN1">*</xref></th>
                <th colspan="2" rowspan="1">u-ALA/creatinine (Î¼mol/mmol)</th>
                <th colspan="2" rowspan="1">u-PBG/creatinine (Î¼mol/mmol)</th>
              </tr>
              <tr>
                <th rowspan="1" colspan="1">Mutation</th>
                <th rowspan="1" colspan="1">No. of patients (number active)</th>
                <th rowspan="1" colspan="1">Range</th>
                <th rowspan="1" colspan="1">Mean</th>
                <th rowspan="1" colspan="1">Range</th>
                <th rowspan="1" colspan="1">Mean</th>
                <th rowspan="1" colspan="1">Range</th>
                <th rowspan="1" colspan="1">Mean</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">Healthy<xref ref-type="table-fn" rid="T1TFN2">â </xref></td>
                <td rowspan="1" colspan="1">â</td>
                <td rowspan="1" colspan="1">0.43â0.89</td>
                <td rowspan="1" colspan="1">â</td>
                <td rowspan="1" colspan="1">&lt;5.0</td>
                <td rowspan="1" colspan="1">â</td>
                <td rowspan="1" colspan="1">&lt;0.8</td>
                <td rowspan="1" colspan="1">â</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">R116W</td>
                <td rowspan="1" colspan="1">18 (15)</td>
                <td rowspan="1" colspan="1">0.20â0.41</td>
                <td rowspan="1" colspan="1">0.29</td>
                <td rowspan="1" colspan="1">1.52â78.39</td>
                <td rowspan="1" colspan="1">10.48</td>
                <td rowspan="1" colspan="1">0.33â46.05</td>
                <td rowspan="1" colspan="1">12.31</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">K132N</td>
                <td rowspan="1" colspan="1">10 (0)</td>
                <td rowspan="1" colspan="1">0.32â0.61</td>
                <td rowspan="1" colspan="1">0.46</td>
                <td rowspan="1" colspan="1">2.08â5.99</td>
                <td rowspan="1" colspan="1">2.93</td>
                <td rowspan="1" colspan="1">0.32â0.54</td>
                <td rowspan="1" colspan="1">0.43</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">R167W</td>
                <td rowspan="1" colspan="1">4 (3)</td>
                <td rowspan="1" colspan="1">0.28â0.42</td>
                <td rowspan="1" colspan="1">0.36</td>
                <td rowspan="1" colspan="1">2.41â8.21</td>
                <td rowspan="1" colspan="1">5.62</td>
                <td rowspan="1" colspan="1">0.35â8.47</td>
                <td rowspan="1" colspan="1">5.39</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">R173W</td>
                <td rowspan="1" colspan="1">4 (3)</td>
                <td rowspan="1" colspan="1">0.19â0.27</td>
                <td rowspan="1" colspan="1">0.24</td>
                <td rowspan="1" colspan="1">1.85â3.27</td>
                <td rowspan="1" colspan="1">2.60</td>
                <td rowspan="1" colspan="1">0.40â1.21</td>
                <td rowspan="1" colspan="1">0.92</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">V215E</td>
                <td rowspan="1" colspan="1">37 (22)</td>
                <td rowspan="1" colspan="1">0.16â0.61</td>
                <td rowspan="1" colspan="1">0.32</td>
                <td rowspan="1" colspan="1">1.20â19.02</td>
                <td rowspan="1" colspan="1">5.18</td>
                <td rowspan="1" colspan="1">0.31â33.89</td>
                <td rowspan="1" colspan="1">5.67</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="T1TFN1">
              <p>*One unit of HMBS activity is 1Â Î¼mol of uroporphyrinogen I/min.</p>
            </fn>
            <fn id="T1TFN2">
              <p><sup>â </sup>Reference values compiled at HUS.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>Expression of recombinant HMBS and mutants</title>
        <p>To study the effect of the newly discovered missense mutations K132N and V215E, together with R116W, R167W and R173W, wt and mutant HMBS were expressed in <italic>E. coli</italic> and purified with high yield (â¥50Â mg wt and mutant HMBS were obtained from 1 l culture) and purity (&gt;95% pure) as seen by SDSâPAGE (<xref ref-type="fig" rid="F1">Figure 1</xref>A). All purified proteins showed distinct SDSâPAGE bands, corresponding to approximately 44Â kDa.</p>
        <fig id="F1" position="float">
          <label>Figure 1</label>
          <caption>
            <title>SDSâPAGE and native PAGE of wt and mutant HMBS</title>
            <p>(<bold>A</bold>) SDSâPAGE showing recombinant HMBS as purified: Wt (lane 1), R116W (lane 2), K132N (lane 3), R167W (lane 4), R173W (lane 5) and V215E (lane 6). Low molecular mass SDSâPAGE standards (lane 7). (<bold>B</bold>) Native PAGE of recombinant HMBS as purified: Wt (lane 1), R116W (lane 2), K132N (lane 3), R167W (lane 4), R173W (lane 5) and V215E (lane 6). See the main text for the interpretation of protein bands.</p>
          </caption>
          <graphic xlink:href="bsr2013-0045i001"/>
        </fig>
        <p>To analyse the enzymeâintermediate complexes the purified enzymes were separated by native PAGE [<xref ref-type="bibr" rid="B14">14</xref>]. Previous reports on native PAGE analyses have shown an inconsistent number of bands for wt HMBS [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B37">37</xref>]. In this work, we found four major bands (<xref ref-type="fig" rid="F1">Figure 1</xref>B), as also reported recently [<xref ref-type="bibr" rid="B37">37</xref>]. Variations in recombinant enzyme purification protocols may lead to loss of enzymeâintermediate complexes [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B38">38</xref>]. The successive increase in negative charge of the intermediates is a result of increased number of PBGs, and the highest band in wt HMBS (<xref ref-type="fig" rid="F1">Figure 1</xref>B, lane 1) is thus interpreted to be the holoenzyme (E) [<xref ref-type="bibr" rid="B37">37</xref>]. Following downwards, the bands have been associated with ES (containing one PBG monomer substrate in addition to the DPM cofactor), ES<sub>2</sub> (two PBGs) and ES<sub>3</sub> (three PBGs) [<xref ref-type="bibr" rid="B37">37</xref>]. All the mutations included in this work are expected to change the charge of the protein at the given pH (8.3) and will give a slightly different maximal migration for the intermediates. Except for K132N, which revealed a similar pattern of bands as wt, all the mutants showed differences in the distribution of bands (<xref ref-type="fig" rid="F1">Figure 1</xref>B). R116W failed to provide discrete bands, although a weak band may be distinguished (* in lane 2; <xref ref-type="fig" rid="F1">Figure 1</xref>B). Based on the instability of this mutant (see below), and its secondary structure content which resembles that of the wt apoenzyme [<xref ref-type="bibr" rid="B39">39</xref>] (see also below), this band may represent a cofactor-free apoform of mutant HMBS [<xref ref-type="bibr" rid="B38">38</xref>]. R167W shows a more complex pattern than wt HMBS with an additional faint band (*<sup>2</sup> in lane 4; <xref ref-type="fig" rid="F1">Figure 1</xref>B) migrating above the E band, possibly representing a partially formed holoenzyme (<xref ref-type="fig" rid="F1">Figure 1</xref>B). Moreover, this mutant also presents a discrete band between E and ES (*<sup>3</sup>), which is also observed as a minor band for wt (lane 1; <xref ref-type="fig" rid="F1">Figure 1</xref>B), and might correspond to a non-identified catalytic intermediate. The unstable R173W (lane 5, <xref ref-type="fig" rid="F1">Figure 1</xref>B) migrated mainly as one band, whereas V215E (lane 6, <xref ref-type="fig" rid="F1">Figure 1</xref>B) showed two additional bands to those observed in wt. The band denoted with *<sup>4</sup> would correspond to *<sup>2</sup> for R167W, and *<sup>5</sup> might indicate an accumulation of the ES<sub>4</sub> intermediate prior to product release. The ES<sub>4</sub> intermediate is normally not observed [<xref ref-type="bibr" rid="B8">8</xref>] other than in situations with slow or no release of the product [<xref ref-type="bibr" rid="B40">40</xref>]. The accumulation of enzymeâintermediates seems to indicate some disturbance in the elongation mechanism which is probably related to the misfolding and instability of V215E (see below).</p>
      </sec>
      <sec>
        <title>Kinetics parameters of wt HMBS and mutants</title>
        <p>The steady-state kinetic characterization of the recombinant wt and mutant enzymes presented here revealed significantly reduced (&lt;5%) relative activity at standard conditions for R116W, R167W and R173W (<xref ref-type="table" rid="T2">Table 2</xref>), as expected [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B41">41</xref>]. The low activity of R116W and R173W precluded the determination of their kinetic parameters. On the other hand, for R167W the large kinetic defect seems to be associated with a very high <italic>K</italic><sub>m</sub> and decreased <italic>V</italic><sub>max</sub> (<xref ref-type="fig" rid="F2">Figure 2</xref>, <xref ref-type="table" rid="T2">Table 2</xref>) as expected from an inefficient elongation process, as described for the R167Q mutant [<xref ref-type="bibr" rid="B28">28</xref>]. No loss in relative activity at standard conditions or change in <italic>V</italic><sub>max</sub> and <italic>K</italic><sub>m</sub>, compared with wt HMBS, was measured for K132N (<xref ref-type="fig" rid="F2">Figure 2</xref>), indicating no apparent kinetic dysfunction. The V215E mutation caused a 70% loss in both activity and <italic>V</italic><sub>max</sub>; however, <italic>K</italic><sub>m</sub> was unchanged (<xref ref-type="fig" rid="F2">Figure 2</xref>, <xref ref-type="table" rid="T2">Table 2</xref>).</p>
        <table-wrap id="T2" position="float">
          <label>Table 2</label>
          <caption>
            <title>Steady-state kinetic parameters of recombinant wt HMBS and mutants</title>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th rowspan="1" colspan="1">Mutation</th>
                <th rowspan="1" colspan="1">Relative activity<xref ref-type="table-fn" rid="T2TFN1">*</xref> (%)</th>
                <th rowspan="1" colspan="1"><italic>V</italic><sub>max</sub> (nmol/h per mg)<xref ref-type="table-fn" rid="T2TFN2">â </xref><xref ref-type="table-fn" rid="T2TFN3">â¡</xref></th>
                <th rowspan="1" colspan="1"><italic>K</italic><sub>m</sub> (PBG) (Î¼M)<xref ref-type="table-fn" rid="T2TFN2">â </xref></th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">Wt</td>
                <td rowspan="1" colspan="1">100</td>
                <td rowspan="1" colspan="1">1261Â±75</td>
                <td rowspan="1" colspan="1">48Â±5</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">R116W</td>
                <td rowspan="1" colspan="1">0.5</td>
                <td rowspan="1" colspan="1">n.a.</td>
                <td rowspan="1" colspan="1">n.a.</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">K132N</td>
                <td rowspan="1" colspan="1">97</td>
                <td rowspan="1" colspan="1">1182Â±78</td>
                <td rowspan="1" colspan="1">41Â±6</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">R167W</td>
                <td rowspan="1" colspan="1">4.2</td>
                <td rowspan="1" colspan="1">615Â±21</td>
                <td rowspan="1" colspan="1">1579Â±111</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">R173W</td>
                <td rowspan="1" colspan="1">0.6</td>
                <td rowspan="1" colspan="1">n.a.</td>
                <td rowspan="1" colspan="1">n.a.</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">V215E</td>
                <td rowspan="1" colspan="1">30</td>
                <td rowspan="1" colspan="1">423Â±36</td>
                <td rowspan="1" colspan="1">39Â±9</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="T2TFN1">
              <p>*Relative activity was measured at standard conditions: wt and mutant HMBS (~5Â Î¼g) and 100Â Î¼M PBG for a reaction time of 4Â min at 37Â°C. The same results were obtained after 20Â min incubation.</p>
            </fn>
            <fn id="T2TFN2">
              <p><sup>â </sup><italic>V</italic><sub>max</sub> and <italic>K</italic><sub>m</sub> were calculated using fitting of the data to MichaelisâMenten kinetics.</p>
            </fn>
            <fn id="T2TFN3">
              <p><sup>â¡</sup>The activity of HMBS was defined as nmol of uroporphyrinogen I/h per mg of enzyme at 37Â°C under the given assay conditions.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <fig id="F2" position="float">
          <label>Figure 2</label>
          <caption>
            <title>The catalytic activity of wt HMBS and mutants as a function of the substrate (PBG) concentration</title>
            <p>Activity is measured as uroporphyrinogen I formation at 37Â°C. Wt (â, <italic>n</italic>=8), K132N (â, <italic>n</italic>=8), R167W (â¡, <italic>n</italic>=12), and V215E (â , <italic>n</italic>=10).</p>
          </caption>
          <graphic xlink:href="bsr2013-0045i002"/>
        </fig>
      </sec>
      <sec>
        <title>Conformational and thermal stability studies</title>
        <p>To better understand the decreased activity of most of the mutants, CD and DSF were applied to investigate the conformation and thermal stability compared with the wt. The far-UV spectrum of wt (<xref ref-type="fig" rid="F3">Figure 3</xref>A) showed two local minima at 208 and 222Â nm, and provided a content in Î±-helical and Î²-sheet structure in accordance with the X-ray crystal structure of the human enzyme [<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B43">43</xref>]. The secondary structure content estimated from the far-UV spectra is given in <xref ref-type="table" rid="T3">Table 3</xref>. Similar results were obtained for K132N and R167W. A mild conformational defect was revealed, however, for R173W, while the large loss of ellipticity at equal protein concentrations observed for R116W and V215E was concurrent with largely decreased Î±-helical content, a feature characteristic of the apoenzyme of <italic>E. coli</italic> HMBS [<xref ref-type="bibr" rid="B39">39</xref>]. Native PAGE supported an unstable apoenzyme conformation for R116W [<xref ref-type="bibr" rid="B44">44</xref>], whereas for V215E a putative species corresponding to the partially formed holoenzyme (*<sup>4</sup>) may also be accompanying the stable intermediates (<xref ref-type="fig" rid="F1">Figure 1</xref>B). The unfolding profiles from temperature-dependent CD shown in <xref ref-type="fig" rid="F3">Figure 3</xref>(B) exhibit the loss of ellipticity for R116W and V215E, as also seen by far-UV. Normalized unfolding profiles of wt and mutants were fitted to a two-state transition model (<xref ref-type="fig" rid="F3">Figure 3</xref>C) and <italic>T</italic><sub>m</sub>-values were extracted, further revealing the large conformational instability of R116W and R173W. For wt HMBS the <italic>T</italic><sub>m</sub> obtained was very high, i.e. <italic>T</italic><sub>m</sub>~74Â°C (<xref ref-type="table" rid="T4">Table 4</xref>), as expected from the high thermal stability of the enzyme activity [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B45">45</xref>]. R116W and R173W displayed lower <italic>T</italic><sub>m</sub>-values, approx. 53 and 60Â°C, respectively (<xref ref-type="fig" rid="F3">Figure 3</xref>C, <xref ref-type="table" rid="T4">Table 4</xref>), reflecting their lower thermal stability, whereas K132N and R167W showed stability similar to that of wt. For the V215E mutant, despite the decrease in ellipticity observed by CD (<xref ref-type="fig" rid="F3">Figures 3</xref>A and <xref ref-type="fig" rid="F3">3</xref>B), temperature-dependent CD provided <italic>T</italic><sub>m</sub> similar to wt. Further insight on this mutant, comparative to the wt and the other mutant forms was obtained by DSF.</p>
        <fig id="F3" position="float">
          <label>Figure 3</label>
          <caption>
            <title>Conformational stability of wt HMBS and mutants, as studied by CD and DSF</title>
            <p>(<bold>A</bold>) Far-UV CD of wt (â), R116W (â²), K132N (â), R167W (â¡), R173W (â) and V215E (â ). [Î¸], mean residue ellipticity. (<bold>B</bold>) The CD-monitored thermal denaturation, presented as mdeg at 222Â nm <italic>versus</italic> temperature. (<bold>C</bold>) The CD-monitored thermal denaturation, normalized to fraction of unfolded protein, and curve fitting to a two-state transition model for wt (1), R116W (2), K132N (3), R167W (4), R173W (5) and V215E (6). (<bold>D</bold>) Thermal denaturation monitored by DSF for wt (â), R116W (â²), K132N (â), R167W (â¡), R173W (â) and V215E (â ). A representative plot of each of four parallels is shown in the figure. The <italic>T</italic><sub>m</sub>-values obtained from (<bold>C</bold>) and (<bold>D</bold>) are summarized in <xref ref-type="table" rid="T4">Table 4</xref>.</p>
          </caption>
          <graphic xlink:href="bsr2013-0045i003"/>
        </fig>
        <table-wrap id="T3" position="float">
          <label>Table 3</label>
          <caption>
            <title>The content of secondary structure in wt HMBS and mutants estimated from far UV CD spectra</title>
            <p>Secondary structure is estimated from far-UV CD spectra using the CDNN algorithm [<xref ref-type="bibr" rid="B37">34</xref>].</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th rowspan="1" colspan="1">Mutation</th>
                <th rowspan="1" colspan="1">Î±-helix (%)</th>
                <th rowspan="1" colspan="1">Î²-sheet (%)</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">Wt</td>
                <td rowspan="1" colspan="1">26.7Â±0.3</td>
                <td rowspan="1" colspan="1">23.4Â±0.3</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Wt (X-ray)<xref ref-type="table-fn" rid="T3TFN1">*</xref></td>
                <td rowspan="1" colspan="1">31.2</td>
                <td rowspan="1" colspan="1">19.8</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">R116W</td>
                <td rowspan="1" colspan="1">16.2Â±0.1</td>
                <td rowspan="1" colspan="1">41.9Â±0.4</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">K132N</td>
                <td rowspan="1" colspan="1">27.0Â±0.7</td>
                <td rowspan="1" colspan="1">24.5Â±1.5</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">R167W</td>
                <td rowspan="1" colspan="1">28.4Â±0.3</td>
                <td rowspan="1" colspan="1">21.8Â±0.3</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">R173W</td>
                <td rowspan="1" colspan="1">24.9Â±0.3</td>
                <td rowspan="1" colspan="1">26.6Â±0.5</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">V215E</td>
                <td rowspan="1" colspan="1">17.7Â±0.2</td>
                <td rowspan="1" colspan="1">38.3Â±0.6</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="T3TFN1">
              <p>*Determined from the crystal structure of the human enzyme (PBD 3ECR) using the DSSP algorithm [<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B43">43</xref>].</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap id="T4" position="float">
          <label>Table 4</label>
          <caption>
            <title>The <italic>T</italic><sub>m</sub> for wt HMBS and mutants as measured by CD and DSF</title>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th rowspan="1" colspan="1"/>
                <th colspan="4" rowspan="1"><italic>T</italic><sub>m</sub>-values (Â°C)</th>
              </tr>
              <tr>
                <th rowspan="1" colspan="1">Mutation</th>
                <th rowspan="1" colspan="1">CD<xref ref-type="table-fn" rid="T4TFN1">*</xref></th>
                <th rowspan="1" colspan="1">DSF<xref ref-type="table-fn" rid="T4TFN2">â </xref></th>
                <th rowspan="1" colspan="1">DSF, <italic>T</italic><sub>m1</sub><xref ref-type="table-fn" rid="T4TFN3">â¡</xref></th>
                <th rowspan="1" colspan="1">DSF, <italic>T</italic><sub>m2</sub><xref ref-type="table-fn" rid="T4TFN3">â¡</xref></th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">Wt</td>
                <td rowspan="1" colspan="1">74.0Â±0.1</td>
                <td rowspan="1" colspan="1">71.1Â±0.6</td>
                <td rowspan="1" colspan="1">54.4Â±0.8<xref ref-type="table-fn" rid="T4TFN4">Â§</xref></td>
                <td rowspan="1" colspan="1">72.8Â±0.3</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">R116W</td>
                <td rowspan="1" colspan="1">53.1Â±0.4</td>
                <td rowspan="1" colspan="1">42.6Â±2.1</td>
                <td rowspan="1" colspan="1">42.1Â±1.7</td>
                <td rowspan="1" colspan="1">â</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">K132N</td>
                <td rowspan="1" colspan="1">74.1Â±0.3</td>
                <td rowspan="1" colspan="1">69.4Â±0.3</td>
                <td rowspan="1" colspan="1">53.3Â±0.5<xref ref-type="table-fn" rid="T4TFN4">Â§</xref></td>
                <td rowspan="1" colspan="1">71.0Â±0.2</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">R167W</td>
                <td rowspan="1" colspan="1">74.3Â±0.0</td>
                <td rowspan="1" colspan="1">67.8Â±0.2</td>
                <td rowspan="1" colspan="1">48.2Â±0.9<xref ref-type="table-fn" rid="T4TFN4">Â§</xref></td>
                <td rowspan="1" colspan="1">70.6Â±0.1</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">R173W</td>
                <td rowspan="1" colspan="1">60.3Â±0.2</td>
                <td rowspan="1" colspan="1">44.5Â±0.6</td>
                <td rowspan="1" colspan="1">45.6Â±0.4</td>
                <td rowspan="1" colspan="1">62.8Â±0.1</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">V215E</td>
                <td rowspan="1" colspan="1">74.5Â±0.3</td>
                <td rowspan="1" colspan="1">54.7Â±2.8</td>
                <td rowspan="1" colspan="1">43.2Â±0.5</td>
                <td rowspan="1" colspan="1">70.3Â±0.4</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="T4TFN1">
              <p>*Determined at fraction of unfolded=0.5 by curve fitting of the thermal transitions [<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B36">36</xref>]. See <xref ref-type="fig" rid="F3">Figure 3</xref>(B).</p>
            </fn>
            <fn id="T4TFN2">
              <p><sup>â </sup>Determined at fraction of unfolded=0.5Â in the thermal transitions. See <xref ref-type="fig" rid="F3">Figure 3</xref>(C).</p>
            </fn>
            <fn id="T4TFN3">
              <p><sup>â¡</sup><italic>T</italic><sub>m1</sub> and <italic>T</italic><sub>m2</sub> were calculated from the first derivative using the transitions observed in the temperature scans. See <xref ref-type="fig" rid="F3">Figure 3</xref>(D).</p>
            </fn>
            <fn id="T4TFN4">
              <p><sup>Â§</sup>Minor transitions.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>DSF (<xref ref-type="fig" rid="F3">Figure 3</xref>D) largely confirmed the results from the CD measurements for wt, R116W, K132N, R167W and R173W, although the <italic>T</italic><sub>m</sub>-values were lower than those obtained by temperature-dependent CD, as summarized in <xref ref-type="table" rid="T4">Table 4</xref>. Moreover, DSF provided evidence for two unfolding transitions for wt and all mutants, except for the most unstable R116W, and hence gave a more detailed insight into the conformational stability of the enzymeâintermediate components in each preparation than temperature-dependent CD. In particular, DSF revealed a large enzyme population with reduced stability (<italic>T</italic><sub>m</sub>=43Â°C) in V215E (<xref ref-type="fig" rid="F3">Figure 3</xref>D, <xref ref-type="table" rid="T4">Table 4</xref>). Both temperature-dependent CD and DSF monitor the unfolding transitions for the overall 3D structure, where thermal CD at 222Â nm follows the unfolding of the secondary structure, notably Î±-helical, and DSF displays the solvent exposure of hydrophobic patches. [<xref ref-type="bibr" rid="B46">46</xref>]. Although the profiles from CD and fluorescence methods are coincident for numerous proteins, different thermal denaturation profiles, and consequently <italic>T</italic><sub>m</sub>-values, might be obtained from these two methods, as has often been observed [<xref ref-type="bibr" rid="B47">47</xref>â<xref ref-type="bibr" rid="B49">49</xref>]. In order to interpret the obtained thermostability data for wt and mutants as isolated we performed stability studies with PBG saturation (see below).</p>
        <p>While the kinetic failure in R116W is associated with a misfolded enzyme unable to acquire cofactor, this is not the case for R173W, which also includes a population of properly folded enzyme as supported by native PAGE, CD and DSF. Moreover, this mutation appears to directly affect the binding of substrate and the elongation mechanism, resulting in accumulation of mainly one intermediate (lane 5; <xref ref-type="fig" rid="F1">Figure 1</xref>B). R167W, on the other hand, is a representative kinetic mutation [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B28">28</xref>], with its conformational change having little effect on the stability of the protein.</p>
      </sec>
      <sec>
        <title>HMBS is destabilized upon substrate saturation</title>
        <p>The thermostability of wt and mutant HMBS was further analysed by DSF in the presence of increasing amounts of the substrate PBG (<xref ref-type="fig" rid="F4">Figure 4</xref>). An increase in thermodynamic stability is usually seen upon ligand binding [<xref ref-type="bibr" rid="B50">50</xref>], and the binding of the DPM cofactor to the apoenzyme triggers a conformational change to a more compact enzyme [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B39">39</xref>]. However, when saturated with 20-fold substrate (100Â Î¼M PBG) both wt HMBS and K132N produced a shift in <italic>T</italic><sub>m</sub>-values (â<italic>T</italic><sub>m</sub>=4.5Â°C) towards lower temperature (<xref ref-type="fig" rid="F4">Figures 4</xref>A and <xref ref-type="fig" rid="F4">4</xref>C). The decreased stability may reflect an overall change in the equilibrium within the intermediates, towards less stable species. A tendency towards a more homogeneous enzyme sample was also seen, as the two observed transitions collapse into one at the highest substrate concentration. Heat treatment in this assay at high concentration of substrate may, however, induce a redistribution of the enzymeâintermediate complexes because of on-going catalysis [<xref ref-type="bibr" rid="B8">8</xref>]. Nevertheless, loss in stability with an increasing number of substrates appears to be in agreement with the suggested opening and loosening of the enzyme structure in order to accommodate the hexapyrrole and to prepare for product release [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>]. Neither R116W nor R173W were affected by the addition of, and saturation with, PBG (<xref ref-type="fig" rid="F4">Figures 4</xref>B and <xref ref-type="fig" rid="F4">4</xref>E), a fact supported by the kinetic analyses. These results agree with previous reports on the lack of proper cofactor or substrate binding and depleted activity of mutants with substitutions at Arg<sup>116</sup> [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B26">26</xref>] and Arg<sup>173</sup> [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B21">21</xref>]. R167W only revealed a decrease in <italic>T</italic><sub>m</sub> when incubated with high PBG concentrations (500 and 1000Â Î¼M) (<xref ref-type="fig" rid="F4">Figure 4</xref>D), in agreement with the high <italic>K</italic><sub>m</sub>-value, indicative of a low affinity for the substrate (<xref ref-type="table" rid="T2">Table 2</xref>). V215E, however, showed a rather different denaturation profile with a noticeable change in distribution with increasing PBG concentration (<xref ref-type="fig" rid="F4">Figure 4</xref>F) where the transition with the lowest stability was shifted towards higher <italic>T</italic><sub>m</sub>. The most stable population (close to wt in <italic>T</italic><sub>m</sub>, see <xref ref-type="table" rid="T4">Table 4</xref>) was less affected. Higher PBG-concentrations (up to 4Â mM, results not shown) did not further affect the denaturation profiles or V215E activity in agreement with a wt-like <italic>K</italic><sub>m</sub> (<xref ref-type="table" rid="T2">Table 2</xref>) indicating that the folding defect is the main contributor to the impaired mechanism of this mutant.</p>
        <fig id="F4" position="float">
          <label>Figure 4</label>
          <caption>
            <title>Thermal stability of wt HMBS and mutants with increasing concentration of PBG</title>
            <p>0Â Î¼M (solid line), 1Â Î¼M (<bold>Â·Â·Â·Â·Â·</bold>), 25Â Î¼M (---), 50Â Î¼M (<bold>Â·Â·</bold>-<bold>Â·Â·</bold>) or 100Â Î¼M (â â) PBG was added to 2Â Î¼M wt HMBS or mutants. For R167W, addition of 500Â Î¼M (<bold>â)</bold> and 1000Â Î¼M (â²) PBG were also analysed. (<bold>A</bold>) For wt HMBS, a Î<italic>T</italic><sub>m</sub>â4.5Â°C was measured at saturating concentration of PBG. (<bold>B</bold>) R116W, Î<italic>T</italic><sub>m</sub>~0Â°C. (<bold>C</bold>) K132N, Î<italic>T</italic><sub>m</sub>~â4.5Â°. (<bold>D</bold>) R167W, Î<italic>T</italic><sub>m</sub>~0Â°C (1â100Â Î¼M PBG). 500 and 1000Â Î¼M PBG gave Î<italic>T</italic><sub>m</sub>~â1.5Â°C and â4Â°C, respectively. (<bold>E</bold>) R173W Î<italic>T</italic><sub>m</sub>~0Â°C. (<bold>F</bold>) V215E was the mutant most affected upon titration with PBG. The first transition (arrow) was clearly stabilized (Î<italic>T</italic><sub>m</sub>~14Â°C) upon saturation with PBG, whereas the second transition was only slightly destabilized (Î<italic>T</italic><sub>m</sub>~â2Â°C).</p>
          </caption>
          <graphic xlink:href="bsr2013-0045i004"/>
        </fig>
        <p>The four bands observed in native PAGE for the purified wt HMBS (lane 1; <xref ref-type="fig" rid="F1">Figure 1</xref>B) were fractionated by anion-exchange chromatography. In addition, we investigated the thermal denaturation of each fractionated peak by DSF. Initially, each peak was analysed by native PAGE (results not shown) and correlated to the major species in <xref ref-type="fig" rid="F1">Figure 1</xref>(B), being E (holoenzyme, peak 1), ES (peak 2), ES<sub>2</sub> (peak 3) and ES<sub>3</sub> (peak 4) (<xref ref-type="fig" rid="F5">Figure 5</xref>A), as previously reported [<xref ref-type="bibr" rid="B37">37</xref>]. The thermal stability of the intermediate complexes revealed that increasing amounts of bound substrate decreased the overall thermal stability of wt HMBS (<xref ref-type="fig" rid="F5">Figure 5</xref>A). Analysis of K132N provided similar results to wt (results not shown) whereas V215E displayed a much larger shift between the peaks with the shortest and the longest retention times (â<italic>T</italic><sub>m</sub>=â18.5Â°C) (<xref ref-type="fig" rid="F5">Figure 5</xref>B). This is in agreement with the complex DSF profile for the unfractionated preparation (<xref ref-type="fig" rid="F3">Figures 3</xref>D and <xref ref-type="fig" rid="F4">4</xref>F). Nevertheless, most of the less stable population seen by DSF (<xref ref-type="fig" rid="F3">Figure 3</xref>D), which probably correspond to the fraction *<sup>4</sup> (lane 6, <xref ref-type="fig" rid="F1">Figure 1</xref>B), is not observed in the fractions, and was most likely lost through aggregation and interaction with the chromatographic material during anion-exchange chromatography.</p>
        <fig id="F5" position="float">
          <label>Figure 5</label>
          <caption>
            <title>DSF of the fractionated peaks obtained from ion-exchange chromatography of wt HMBS and the V215E mutant</title>
            <p>(<bold>A</bold>) For wt HMBS, the unfolding transitions show decreasing thermal stability with increasing retention time, indicating that the stability is decreased with increasing amount of bound PBG-molecules (E, peak 1; ES, peak 2; ES<sub>2</sub>, peak 3; ES<sub>3</sub>, peak 4). â<italic>T</italic><sub>m</sub> is~â5Â°C from peak 1 to peak 4. The inset shows the ion-exchange chromatography profile. (<bold>B</bold>) For V215E, the ion-exchange chromatography profile shows a rather similar pattern to that of wt, but further investigation with DSF reveals a wider span of thermal stability (â<italic>T</italic><sub>m</sub>=â18.5Â°C) for the fractions obtained for this mutant.</p>
          </caption>
          <graphic xlink:href="bsr2013-0045i005"/>
        </fig>
      </sec>
      <sec>
        <title>Conclusion</title>
        <p>In this work, we have acquired knowledge on the conformational stability of wt HMBS and selected mutants, as well as gained insight into the elongation process of the HMBS catalysis. The results also contribute to the understanding of the phenotype-genotype correlations in AIP. R116W and R173W, the two mutants with the most severe phenotype, present an almost total kinetic dysfunction which is largely associated with their severe conformational instability. R167W presents a less severe phenotype yet high association with AIP, and the clinical profile is mainly associated with a catalytic disruption. The novel mutation investigated in this work, K132N, has an unclear clinical significance, and our results show similar kinetic, conformational and thermal stability to wt HMBS, supporting that this mutation does not induce or cause classical AIP symptoms or biochemical findings. Lys<sup>132</sup> is localized on the surface of domain 2, away from the active site, and is most likely not directly involved in the synthesis of HMB. The previously reported, although uncharacterized, V215E is located in the vicinity of the active site, and is part of a hinge region connecting domains 1 and 2. Although not interacting directly with the cofactor, the substitution of a hydrophobic Val with a negatively charged Glu residue in this position appears to alter intramolecular interactions, affecting the folding and stability of the enzyme, and the faulty mechanism of V215E appears to be the result of the folding defects. There seems to be a close relationship between the biochemical characteristics of the isolated recombinant enzyme, the biochemical phenotype, and the AIP association. The patients are highly affected, with 59% experiencing attacks, and our findings correlate with the high disease association.</p>
        <p>Our results contribute to increasing our knowledge and understanding of the complete biochemical mechanism and the molecular basis for the phenotypic outcome of HMBS mutants, which is important in the future investigation of treatments for AIP.</p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Online data</title>
      <supplementary-material id="SD1" content-type="local-data" position="float" xlink:type="simple">
        <caption>
          <title>Supplementary data</title>
        </caption>
        <media mimetype="application" mime-subtype="pdf" xlink:href="bsr033e056add.pdf" position="float" xlink:type="simple"/>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <title>ACKNOWLEDGEMENTS</title>
      <p>We thank Aasne K. Aarsand and JÃ¸rild Haugen Villanger for excellent help and data extraction from the NPR, and Jarl Underhaug for help with analysis of DSF data. Lars SkjÃ¦rven is thanked for modelling and minimization of HMBS structures. We are grateful to Philip R.A. Webber who thoroughly read the manuscript.</p>
    </ack>
    <sec>
      <title>AUTHOR CONTRIBUTION</title>
      <p>Helene J. Bustad designed and performed experiments, analysed data, and wrote the paper with contributions from all authors. Marta Vorland and Eva RÃ¸nneseth performed experiments and analysed data. Sverre Sandberg managed the project, and provided the clinical and biochemical patient data. Aurora Martinez managed and supervised the project, and analysed data. Karen Toska supervised the project, performed experiments and analysed data.</p>
    </sec>
    <sec>
      <title>FUNDING</title>
      <p>This work was supported by the <funding-source id="gs1">Research Council of Norway</funding-source>, the <funding-source id="gs2">Western Norway Regional Health Authority</funding-source> and the <funding-source id="gs3">Norwegian Porphyria Centre.</funding-source></p>
    </sec>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>C. S.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>M. J.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>S. B.</given-names>
            </name>
            <name>
              <surname>Kiernan</surname>
              <given-names>M. C.</given-names>
            </name>
          </person-group>
          <article-title>Purple pigments: the pathophysiology of acute porphyric neuropathy</article-title>
          <source>Clin. Neurophysiol.</source>
          <year>2011</year>
          <volume>122</volume>
          <fpage>2336</fpage>
          <lpage>2344</lpage>
          <pub-id pub-id-type="pmid">21855406</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Herrick</surname>
              <given-names>A. L.</given-names>
            </name>
            <name>
              <surname>McColl</surname>
              <given-names>K. E.</given-names>
            </name>
          </person-group>
          <article-title>Acute intermittent porphyria</article-title>
          <source>Best Pract. Res. Clin. Gastroenterol.</source>
          <year>2005</year>
          <volume>19</volume>
          <fpage>235</fpage>
          <lpage>249</lpage>
          <pub-id pub-id-type="pmid">15833690</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grandchamp</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>De Verneuil</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Beaumont</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Chretien</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Walter</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Nordmann</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Tissue-specific expression of porphobilinogen deaminase. Two isoenzymes from a single gene</article-title>
          <source>Eur. J. Biochem.</source>
          <year>1987</year>
          <volume>162</volume>
          <fpage>105</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="pmid">3816774</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brons-Poulsen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Christiansen</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Petersen</surname>
              <given-names>N. E.</given-names>
            </name>
            <name>
              <surname>Horder</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kristiansen</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Characterization of two isoalleles and three mutations in both isoforms of purified recombinant human porphobilinogen deaminase</article-title>
          <source>Scand. J. Clin. Lab. Invest.</source>
          <year>2005</year>
          <volume>65</volume>
          <fpage>93</fpage>
          <lpage>105</lpage>
          <pub-id pub-id-type="pmid">16025832</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Song</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Joachimiak</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Z. J.</given-names>
            </name>
          </person-group>
          <article-title>Structural insight into acute intermittent porphyria</article-title>
          <source>FASEB J.</source>
          <year>2009</year>
          <volume>23</volume>
          <fpage>396</fpage>
          <lpage>404</lpage>
          <pub-id pub-id-type="pmid">18936296</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gill</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Kolstoe</surname>
              <given-names>S. E.</given-names>
            </name>
            <name>
              <surname>Mohammed</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Al D-Bass</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Mosely</surname>
              <given-names>J. E.</given-names>
            </name>
            <name>
              <surname>Sarwar</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>J. B.</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>S. P.</given-names>
            </name>
            <name>
              <surname>Shoolingin-Jordan</surname>
              <given-names>P. M.</given-names>
            </name>
          </person-group>
          <article-title>Structure of human porphobilinogen deaminase at 2.8 Ã: the molecular basis of acute intermittent porphyria</article-title>
          <source>Biochem. J.</source>
          <year>2009</year>
          <volume>420</volume>
          <fpage>17</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="pmid">19207107</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Layer</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Reichelt</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Jahn</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Heinz</surname>
              <given-names>D. W.</given-names>
            </name>
          </person-group>
          <article-title>Structure and function of enzymes in heme biosynthesis</article-title>
          <source>Protein Sci.</source>
          <year>2010</year>
          <volume>19</volume>
          <fpage>1137</fpage>
          <lpage>1161</lpage>
          <pub-id pub-id-type="pmid">20506125</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Warren</surname>
              <given-names>M. J.</given-names>
            </name>
            <name>
              <surname>Jordan</surname>
              <given-names>P. M.</given-names>
            </name>
          </person-group>
          <article-title>Investigation into the nature of substrate binding to the dipyrromethane cofactor of <italic>Escherichia coli</italic> porphobilinogen deaminase</article-title>
          <source>Biochemistry</source>
          <year>1988</year>
          <volume>27</volume>
          <fpage>9020</fpage>
          <lpage>9030</lpage>
          <pub-id pub-id-type="pmid">3069132</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jordan</surname>
              <given-names>P. M.</given-names>
            </name>
            <name>
              <surname>Warren</surname>
              <given-names>M. J.</given-names>
            </name>
          </person-group>
          <article-title>Evidence for a dipyrromethane cofactor at the catalytic site of <italic>E. coli</italic> porphobilinogen deaminase</article-title>
          <source>FEBS Lett.</source>
          <year>1987</year>
          <volume>225</volume>
          <fpage>87</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="pmid">3079571</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pichon</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Clemens</surname>
              <given-names>K. R.</given-names>
            </name>
            <name>
              <surname>Jacobson</surname>
              <given-names>A. R.</given-names>
            </name>
            <name>
              <surname>Scott</surname>
              <given-names>A. I.</given-names>
            </name>
          </person-group>
          <article-title>On the mechanism of porphobilinogen deaminaseâdesign, synthesis, and enzymatic-reactions of novel porphobilinogen analogs</article-title>
          <source>Tetrahedron</source>
          <year>1992</year>
          <volume>48</volume>
          <fpage>4687</fpage>
          <lpage>4712</lpage>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Warren</surname>
              <given-names>M. J.</given-names>
            </name>
            <name>
              <surname>Gul</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Aplin</surname>
              <given-names>R. T.</given-names>
            </name>
            <name>
              <surname>Scott</surname>
              <given-names>A. I.</given-names>
            </name>
            <name>
              <surname>Roessner</surname>
              <given-names>C. A.</given-names>
            </name>
            <name>
              <surname>OâGrady</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Shoolingin-Jordan</surname>
              <given-names>P. M.</given-names>
            </name>
          </person-group>
          <article-title>Evidence for conformational changes in <italic>Escherichia coli</italic> porphobilinogen deaminase during stepwise pyrrole chain elongation monitored by increased reactivity of cysteine-134 to alkylation by N-ethylmaleimide</article-title>
          <source>Biochemistry</source>
          <year>1995</year>
          <volume>34</volume>
          <fpage>11288</fpage>
          <lpage>11295</lpage>
          <pub-id pub-id-type="pmid">7669787</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Noriega</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Mattei</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Batlle</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Juknat</surname>
              <given-names>A. A.</given-names>
            </name>
          </person-group>
          <article-title>Rat kidney porphobilinogen deaminase kinetics. Detection of enzymeâsubstrate complexes</article-title>
          <source>Int. J. Biochem. Cell Biol.</source>
          <year>2002</year>
          <volume>34</volume>
          <fpage>1230</fpage>
          <lpage>1240</lpage>
          <pub-id pub-id-type="pmid">12127573</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Louie</surname>
              <given-names>G. V.</given-names>
            </name>
            <name>
              <surname>Brownlie</surname>
              <given-names>P. D.</given-names>
            </name>
            <name>
              <surname>Lambert</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>J. B.</given-names>
            </name>
            <name>
              <surname>Blundell</surname>
              <given-names>T. L.</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>S. P.</given-names>
            </name>
            <name>
              <surname>Warren</surname>
              <given-names>M. J.</given-names>
            </name>
            <name>
              <surname>Woodcock</surname>
              <given-names>S. C.</given-names>
            </name>
            <name>
              <surname>Jordan</surname>
              <given-names>P. M.</given-names>
            </name>
          </person-group>
          <article-title>Structure of porphobilinogen deaminase reveals a flexible multidomain polymerase with a single catalytic site</article-title>
          <source>Nature</source>
          <year>1992</year>
          <volume>359</volume>
          <fpage>33</fpage>
          <lpage>39</lpage>
          <pub-id pub-id-type="pmid">1522882</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jordan</surname>
              <given-names>P. M.</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>S. D.</given-names>
            </name>
            <name>
              <surname>Warren</surname>
              <given-names>M. J.</given-names>
            </name>
          </person-group>
          <article-title>Purification, crystallization and properties of porphobilinogen deaminase from a recombinant strain of <italic>Escherichia coli</italic> K12</article-title>
          <source>Biochem. J.</source>
          <year>1988</year>
          <volume>254</volume>
          <fpage>427</fpage>
          <lpage>435</lpage>
          <pub-id pub-id-type="pmid">3052434</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>C. H.</given-names>
            </name>
            <name>
              <surname>Astrin</surname>
              <given-names>K. H.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>K. E.</given-names>
            </name>
            <name>
              <surname>Desnick</surname>
              <given-names>R. J.</given-names>
            </name>
          </person-group>
          <article-title>Acute intermittent porphyria: identification and expression of exonic mutations in the hydroxymethylbilane synthase gene. An initiation codon missense mutation in the housekeeping transcript causes âvariant acute intermittent porphyriaâ with normal expression of the erythroid-specific enzyme</article-title>
          <source>J. Clin. Invest.</source>
          <year>1994</year>
          <volume>94</volume>
          <fpage>1927</fpage>
          <lpage>1937</lpage>
          <pub-id pub-id-type="pmid">7962538</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scott</surname>
              <given-names>A. I.</given-names>
            </name>
            <name>
              <surname>Clemens</surname>
              <given-names>K. R.</given-names>
            </name>
            <name>
              <surname>Stolowich</surname>
              <given-names>N. J.</given-names>
            </name>
            <name>
              <surname>Santander</surname>
              <given-names>P. J.</given-names>
            </name>
            <name>
              <surname>Gonzalez</surname>
              <given-names>M. D.</given-names>
            </name>
            <name>
              <surname>Roessner</surname>
              <given-names>C. A.</given-names>
            </name>
          </person-group>
          <article-title>Reconstitution of apo-porphobilinogen deaminase: structural changes induced by cofactor binding</article-title>
          <source>FEBS Lett.</source>
          <year>1989</year>
          <volume>242</volume>
          <fpage>319</fpage>
          <lpage>324</lpage>
          <pub-id pub-id-type="pmid">2644132</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tjensvoll</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Bruland</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Floderus</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Skadberg</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Sandberg</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Apold</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Haplotype analysis of Norwegian and Swedish patients with acute intermittent porphyria (AIP): extreme haplotype heterogeneity for the mutation R116W</article-title>
          <source>Dis. Markers</source>
          <year>2003</year>
          <volume>19</volume>
          <fpage>41</fpage>
          <lpage>46</lpage>
          <pub-id pub-id-type="pmid">14757946</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gu</surname>
              <given-names>X. F.</given-names>
            </name>
            <name>
              <surname>de Rooij</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>J. S.</given-names>
            </name>
            <name>
              <surname>Te Velde</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Deybach</surname>
              <given-names>J. C.</given-names>
            </name>
            <name>
              <surname>Nordmann</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Grandchamp</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>High prevalence of a point mutation in the porphobilinogen deaminase gene in Dutch patients with acute intermittent porphyria</article-title>
          <source>Hum. Genet.</source>
          <year>1993</year>
          <volume>91</volume>
          <fpage>128</fpage>
          <lpage>130</lpage>
          <pub-id pub-id-type="pmid">8096492</pub-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kauppinen</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Mustajoki</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Pihlaja</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Peltonen</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Mustajoki</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Acute intermittent porphyria in Finland: 19 mutations in the porphobilinogen deaminase gene</article-title>
          <source>Hum. Mol. Genet.</source>
          <year>1995</year>
          <volume>4</volume>
          <fpage>215</fpage>
          <lpage>222</lpage>
          <pub-id pub-id-type="pmid">7757070</pub-id>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>von und zu Fraunberg</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Pischik</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Udd</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Kauppinen</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Clinical and biochemical characteristics and genotype-phenotype correlation in 143 Finnish and Russian patients with acute intermittent porphyria</article-title>
          <source>Medicine</source>
          <year>2005</year>
          <volume>84</volume>
          <publisher-loc>Philadelphia, PA, USA</publisher-loc>
          <fpage>35</fpage>
          <lpage>47</lpage>
          <pub-id pub-id-type="pmid">15643298</pub-id>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mustajoki</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Laine</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lahtela</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Mustajoki</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Peltonen</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Kauppinen</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Acute intermittent porphyria: expression of mutant and wild-type porphobilinogen deaminase in COS-1 cells</article-title>
          <source>Mol. Med.</source>
          <year>2000</year>
          <volume>6</volume>
          <fpage>670</fpage>
          <lpage>679</lpage>
          <pub-id pub-id-type="pmid">11055586</pub-id>
        </element-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Floderus</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Shoolingin-Jordan</surname>
              <given-names>P. M.</given-names>
            </name>
            <name>
              <surname>Harper</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Acute intermittent porphyria in Sweden. Molecular, functional and clinical consequences of some new mutations found in the porphobilinogen deaminase gene</article-title>
          <source>Clin. Genet.</source>
          <year>2002</year>
          <volume>62</volume>
          <fpage>288</fpage>
          <lpage>297</lpage>
          <pub-id pub-id-type="pmid">12372055</pub-id>
        </element-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mgone</surname>
              <given-names>C. S.</given-names>
            </name>
            <name>
              <surname>Lanyon</surname>
              <given-names>W. G.</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>M. R.</given-names>
            </name>
            <name>
              <surname>Louie</surname>
              <given-names>G. V.</given-names>
            </name>
            <name>
              <surname>Connor</surname>
              <given-names>J. M.</given-names>
            </name>
          </person-group>
          <article-title>Identification of five novel mutations in the porphobilinogen deaminase gene</article-title>
          <source>Hum. Mol. Genet.</source>
          <year>1994</year>
          <volume>3</volume>
          <fpage>809</fpage>
          <lpage>811</lpage>
          <pub-id pub-id-type="pmid">8081367</pub-id>
        </element-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Solis</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Lopez-Echaniz</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Sefarty-Graneda</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Astrin</surname>
              <given-names>K. H.</given-names>
            </name>
            <name>
              <surname>Desnick</surname>
              <given-names>R. J.</given-names>
            </name>
          </person-group>
          <article-title>Identification and expression of mutations in the hydroxymethylbilane synthase gene causing acute intermittent porphyria (AIP)</article-title>
          <source>Mol. Med.</source>
          <year>1999</year>
          <volume>5</volume>
          <fpage>664</fpage>
          <lpage>671</lpage>
          <pub-id pub-id-type="pmid">10602775</pub-id>
        </element-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brownlie</surname>
              <given-names>P. D.</given-names>
            </name>
            <name>
              <surname>Lambert</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Louie</surname>
              <given-names>G. V.</given-names>
            </name>
            <name>
              <surname>Jordan</surname>
              <given-names>P. M.</given-names>
            </name>
            <name>
              <surname>Blundell</surname>
              <given-names>T. L.</given-names>
            </name>
            <name>
              <surname>Warren</surname>
              <given-names>M. J.</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>J. B.</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>S. P.</given-names>
            </name>
          </person-group>
          <article-title>The three-dimensional structures of mutants of porphobilinogen deaminase: toward an understanding of the structural basis of acute intermittent porphyria</article-title>
          <source>Protein Sci.</source>
          <year>1994</year>
          <volume>3</volume>
          <fpage>1644</fpage>
          <lpage>1650</lpage>
          <pub-id pub-id-type="pmid">7849582</pub-id>
        </element-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ong</surname>
              <given-names>P. M.</given-names>
            </name>
            <name>
              <surname>Lanyon</surname>
              <given-names>W. G.</given-names>
            </name>
            <name>
              <surname>Graham</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Hift</surname>
              <given-names>R. J.</given-names>
            </name>
            <name>
              <surname>Halkett</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>M. R.</given-names>
            </name>
            <name>
              <surname>Connor</surname>
              <given-names>J. M.</given-names>
            </name>
          </person-group>
          <article-title>Acute intermittent porphyria: the <italic>inÂ vitro</italic> expression of mutant hydroxymethylbilane synthase</article-title>
          <source>Mol. Cell. Probes</source>
          <year>1997</year>
          <volume>11</volume>
          <fpage>293</fpage>
          <lpage>296</lpage>
          <pub-id pub-id-type="pmid">9281416</pub-id>
        </element-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jordan</surname>
              <given-names>P. M.</given-names>
            </name>
            <name>
              <surname>Woodcock</surname>
              <given-names>S. C.</given-names>
            </name>
          </person-group>
          <article-title>Mutagenesis of arginine residues in the catalytic cleft of <italic>Escherichia coli</italic> porphobilinogen deaminase that affects dipyrromethane cofactor assembly and tetrapyrrole chain initiation and elongation</article-title>
          <source>Biochem. J.</source>
          <year>1991</year>
          <volume>280</volume>
          <issue>Pt 2</issue>
          <fpage>445</fpage>
          <lpage>449</lpage>
          <pub-id pub-id-type="pmid">1747120</pub-id>
        </element-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shoolingin-Jordan</surname>
              <given-names>P. M.</given-names>
            </name>
            <name>
              <surname>Al-Dbass</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>McNeill</surname>
              <given-names>L. A.</given-names>
            </name>
            <name>
              <surname>Sarwar</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Butler</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Human porphobilinogen deaminase mutations in the investigation of the mechanism of dipyrromethane cofactor assembly and tetrapyrrole formation</article-title>
          <source>Biochem. Soc. Trans.</source>
          <year>2003</year>
          <volume>31</volume>
          <fpage>731</fpage>
          <lpage>735</lpage>
          <pub-id pub-id-type="pmid">12773194</pub-id>
        </element-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mauzerall</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Granick</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>The occurrence and determination of Î´-aminolevulinic acid and porphobilinogen in urine</article-title>
          <source>J. Biol. Chem.</source>
          <year>1956</year>
          <volume>219</volume>
          <fpage>435</fpage>
          <lpage>446</lpage>
          <pub-id pub-id-type="pmid">13295297</pub-id>
        </element-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ford</surname>
              <given-names>R. E.</given-names>
            </name>
            <name>
              <surname>Ou</surname>
              <given-names>C. N.</given-names>
            </name>
            <name>
              <surname>Ellefson</surname>
              <given-names>R. D.</given-names>
            </name>
          </person-group>
          <article-title>Assay for erythrocyte uroporphyrinogen I synthase activity, with porphobilinogen as substrate</article-title>
          <source>Clin. Chem.</source>
          <year>1980</year>
          <volume>26</volume>
          <fpage>1182</fpage>
          <lpage>1185</lpage>
          <pub-id pub-id-type="pmid">7389090</pub-id>
        </element-citation>
      </ref>
      <ref id="B31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ulbrichova</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Flachsova</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Hrdinka</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Saligova</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Bazar</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Raman</surname>
              <given-names>C. S.</given-names>
            </name>
            <name>
              <surname>Martasek</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>De Novo mutation found in the porphobilinogen deaminase gene in Slovak acute intermittent porphyria patient: molecular biochemical study</article-title>
          <source>Physiol. Res.</source>
          <year>2006</year>
          <volume>55</volume>
          <issue>Suppl. 2</issue>
          <fpage>S145</fpage>
          <lpage>S154</lpage>
          <pub-id pub-id-type="pmid">17298218</pub-id>
        </element-citation>
      </ref>
      <ref id="B32">
        <label>32</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Gasteiger</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Hoogland</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Gattiker</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Duvaud</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wilkins</surname>
              <given-names>M. R.</given-names>
            </name>
            <name>
              <surname>Appel</surname>
              <given-names>R. D.</given-names>
            </name>
            <name>
              <surname>Bairoch</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Walker</surname>
              <given-names>J. M.</given-names>
            </name>
          </person-group>
          <article-title>Protein Identification and Analysis Tools on the ExPASy ServerProteomics protocols handbook</article-title>
          <source>Proteomics Protocols Handbook</source>
          <year>2005</year>
          <publisher-loc>Totowa, NJ, USA</publisher-loc>
          <publisher-name>Humana Press</publisher-name>
          <fpage>571</fpage>
          <lpage>607</lpage>
        </element-citation>
      </ref>
      <ref id="B33">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Laemmli</surname>
              <given-names>U. K.</given-names>
            </name>
          </person-group>
          <article-title>Cleavage of structural proteins during the assembly of the head of bacteriophage T4</article-title>
          <source>Nature</source>
          <year>1970</year>
          <volume>227</volume>
          <fpage>680</fpage>
          <lpage>685</lpage>
          <pub-id pub-id-type="pmid">5432063</pub-id>
        </element-citation>
      </ref>
      <ref id="B34">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bohm</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Muhr</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Jaenicke</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Quantitative analysis of protein far UV circular dichroism spectra by neural networks</article-title>
          <source>Protein Eng.</source>
          <year>1992</year>
          <volume>5</volume>
          <fpage>191</fpage>
          <lpage>195</lpage>
          <pub-id pub-id-type="pmid">1409538</pub-id>
        </element-citation>
      </ref>
      <ref id="B35">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Swint</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Robertson</surname>
              <given-names>A. D.</given-names>
            </name>
          </person-group>
          <article-title>Thermodynamics of unfolding for turkey ovomucoid third domain: thermal and chemical denaturation</article-title>
          <source>Protein Sci.</source>
          <year>1993</year>
          <volume>2</volume>
          <fpage>2037</fpage>
          <lpage>2049</lpage>
          <pub-id pub-id-type="pmid">8298454</pub-id>
        </element-citation>
      </ref>
      <ref id="B36">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Agashe</surname>
              <given-names>V. R.</given-names>
            </name>
            <name>
              <surname>Udgaonkar</surname>
              <given-names>J. B.</given-names>
            </name>
          </person-group>
          <article-title>Thermodynamics of denaturation of barstar: evidence for cold denaturation and evaluation of the interaction with guanidine hydrochloride</article-title>
          <source>Biochemistry</source>
          <year>1995</year>
          <volume>34</volume>
          <fpage>3286</fpage>
          <lpage>3299</lpage>
          <pub-id pub-id-type="pmid">7880824</pub-id>
        </element-citation>
      </ref>
      <ref id="B37">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Chu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Functional studies of rat hydroxymethylbilane synthase</article-title>
          <source>Bioorg. Chem.</source>
          <year>2008</year>
          <volume>36</volume>
          <fpage>241</fpage>
          <lpage>251</lpage>
          <pub-id pub-id-type="pmid">18760440</pub-id>
        </element-citation>
      </ref>
      <ref id="B38">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shoolingin-Jordan</surname>
              <given-names>P. M.</given-names>
            </name>
            <name>
              <surname>Warren</surname>
              <given-names>M. J.</given-names>
            </name>
            <name>
              <surname>Awan</surname>
              <given-names>S. J.</given-names>
            </name>
          </person-group>
          <article-title>Discovery that the assembly of the dipyrromethane cofactor of porphobilinogen deaminase holoenzyme proceeds initially by the reaction of preuroporphyrinogen with the apoenzyme</article-title>
          <source>Biochem. J.</source>
          <year>1996</year>
          <volume>316</volume>
          <issue>Pt 2</issue>
          <fpage>373</fpage>
          <lpage>376</lpage>
          <pub-id pub-id-type="pmid">8687374</pub-id>
        </element-citation>
      </ref>
      <ref id="B39">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Awan</surname>
              <given-names>S. J.</given-names>
            </name>
            <name>
              <surname>Siligardi</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Shoolingin-Jordan</surname>
              <given-names>P. M.</given-names>
            </name>
            <name>
              <surname>Warren</surname>
              <given-names>M. J.</given-names>
            </name>
          </person-group>
          <article-title>Reconstitution of the holoenzyme form of <italic>Escherichia coli</italic> porphobilinogen deaminase from apoenzyme with porphobilinogen and preuroporphyrinogen: a study using circular dichroism spectroscopy</article-title>
          <source>Biochemistry</source>
          <year>1997</year>
          <volume>36</volume>
          <fpage>9273</fpage>
          <lpage>9282</lpage>
          <pub-id pub-id-type="pmid">9230062</pub-id>
        </element-citation>
      </ref>
      <ref id="B40">
        <label>40</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lander</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Pitt</surname>
              <given-names>A. R.</given-names>
            </name>
            <name>
              <surname>Alefounder</surname>
              <given-names>P. R.</given-names>
            </name>
            <name>
              <surname>Bardy</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Abell</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Battersby</surname>
              <given-names>A. R.</given-names>
            </name>
          </person-group>
          <article-title>Studies on the mechanism of hydroxymethylbilane synthase concerning the role of arginine residues in substrate binding</article-title>
          <source>Biochem. J.</source>
          <year>1991</year>
          <volume>275</volume>
          <issue>Pt 2</issue>
          <fpage>447</fpage>
          <lpage>452</lpage>
          <pub-id pub-id-type="pmid">2025226</pub-id>
        </element-citation>
      </ref>
      <ref id="B41">
        <label>41</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gu</surname>
              <given-names>X. F.</given-names>
            </name>
            <name>
              <surname>de Rooij</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Voortman</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Te Velde</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Nordmann</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Grandchamp</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>High frequency of mutations in exon 10 of the porphobilinogen deaminase gene in patients with a CRIM-positive subtype of acute intermittent porphyria</article-title>
          <source>Am. J. Hum. Genet.</source>
          <year>1992</year>
          <volume>51</volume>
          <fpage>660</fpage>
          <lpage>665</lpage>
          <pub-id pub-id-type="pmid">1496994</pub-id>
        </element-citation>
      </ref>
      <ref id="B42">
        <label>42</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Joosten</surname>
              <given-names>R. P.</given-names>
            </name>
            <name>
              <surname>te Beek</surname>
              <given-names>T. A.</given-names>
            </name>
            <name>
              <surname>Krieger</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Hekkelman</surname>
              <given-names>M. L.</given-names>
            </name>
            <name>
              <surname>Hooft</surname>
              <given-names>R. W.</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Sander</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Vriend</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>A series of PDB related databases for everyday needs</article-title>
          <source>Nucleic Acids Res.</source>
          <year>2011</year>
          <volume>39</volume>
          <fpage>D411</fpage>
          <lpage>D419</lpage>
          <pub-id pub-id-type="pmid">21071423</pub-id>
        </element-citation>
      </ref>
      <ref id="B43">
        <label>43</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kabsch</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Sander</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features</article-title>
          <source>Biopolymers</source>
          <year>1983</year>
          <volume>22</volume>
          <fpage>2577</fpage>
          <lpage>2637</lpage>
          <pub-id pub-id-type="pmid">6667333</pub-id>
        </element-citation>
      </ref>
      <ref id="B44">
        <label>44</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shoolingin-Jordan</surname>
              <given-names>P. M.</given-names>
            </name>
            <name>
              <surname>Warren</surname>
              <given-names>M. J.</given-names>
            </name>
            <name>
              <surname>Awan</surname>
              <given-names>S. J.</given-names>
            </name>
          </person-group>
          <article-title>Dipyrromethane cofactor assembly of porphobilinogen deaminase: formation of apoenzyme and preparation of holoenzyme</article-title>
          <source>Methods Enzymol.</source>
          <year>1997</year>
          <volume>281</volume>
          <fpage>317</fpage>
          <lpage>327</lpage>
          <pub-id pub-id-type="pmid">9250996</pub-id>
        </element-citation>
      </ref>
      <ref id="B45">
        <label>45</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schneider-Yin</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Ulbrichova</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Mamet</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Martasek</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Marohnic</surname>
              <given-names>C. C.</given-names>
            </name>
            <name>
              <surname>Goren</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Minder</surname>
              <given-names>E. I.</given-names>
            </name>
            <name>
              <surname>Schoenfeld</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Characterization of two missense variants in the hydroxymethylbilane synthase gene in the Israeli population, which differ in their associations with acute intermittent porphyria</article-title>
          <source>Mol. Genet. Metab.</source>
          <year>2008</year>
          <volume>94</volume>
          <fpage>343</fpage>
          <lpage>346</lpage>
          <pub-id pub-id-type="pmid">18406650</pub-id>
        </element-citation>
      </ref>
      <ref id="B46">
        <label>46</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Niesen</surname>
              <given-names>F. H.</given-names>
            </name>
            <name>
              <surname>Berglund</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Vedadi</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability</article-title>
          <source>Nat. Protoc.</source>
          <year>2007</year>
          <volume>2</volume>
          <fpage>2212</fpage>
          <lpage>2221</lpage>
          <pub-id pub-id-type="pmid">17853878</pub-id>
        </element-citation>
      </ref>
      <ref id="B47">
        <label>47</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Halskau</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Underhaug</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Froystein</surname>
              <given-names>N. A.</given-names>
            </name>
            <name>
              <surname>Martinez</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Conformational flexibility of alpha-lactalbumin related to its membrane binding capacity</article-title>
          <source>J. Mol. Biol.</source>
          <year>2005</year>
          <volume>349</volume>
          <fpage>1072</fpage>
          <lpage>1086</lpage>
          <pub-id pub-id-type="pmid">15913646</pub-id>
        </element-citation>
      </ref>
      <ref id="B48">
        <label>48</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Devenish</surname>
              <given-names>S. R.</given-names>
            </name>
            <name>
              <surname>Huisman</surname>
              <given-names>F. H.</given-names>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>E. J.</given-names>
            </name>
            <name>
              <surname>Hadfield</surname>
              <given-names>A. T.</given-names>
            </name>
            <name>
              <surname>Gerrard</surname>
              <given-names>J. A.</given-names>
            </name>
          </person-group>
          <article-title>Cloning and characterisation of dihydrodipicolinate synthase from the pathogen Neisseria meningitidis</article-title>
          <source>Biochim. Biophys. Acta</source>
          <year>2009</year>
          <volume>1794</volume>
          <fpage>1168</fpage>
          <lpage>1174</lpage>
          <pub-id pub-id-type="pmid">19236959</pub-id>
        </element-citation>
      </ref>
      <ref id="B49">
        <label>49</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lidon-Moya</surname>
              <given-names>M. C.</given-names>
            </name>
            <name>
              <surname>Barrera</surname>
              <given-names>F. N.</given-names>
            </name>
            <name>
              <surname>Bueno</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Perez-Jimenez</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Sancho</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Mateu</surname>
              <given-names>M. G.</given-names>
            </name>
            <name>
              <surname>Neira</surname>
              <given-names>J. L.</given-names>
            </name>
          </person-group>
          <article-title>An extensive thermodynamic characterization of the dimerization domain of the HIV-1 capsid protein</article-title>
          <source>Protein Sci.</source>
          <year>2005</year>
          <volume>14</volume>
          <fpage>2387</fpage>
          <lpage>2404</lpage>
          <pub-id pub-id-type="pmid">16131662</pub-id>
        </element-citation>
      </ref>
      <ref id="B50">
        <label>50</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sanchez-Ruiz</surname>
              <given-names>J. M.</given-names>
            </name>
          </person-group>
          <article-title>Ligand effects on protein thermodynamic stability</article-title>
          <source>Biophys. Chem.</source>
          <year>2007</year>
          <volume>126</volume>
          <fpage>43</fpage>
          <lpage>49</lpage>
          <pub-id pub-id-type="pmid">16781051</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>